Analysis of the Comparative Workflow and Performance Characteristics of the VITEK 2 and Phoenix Systems

Author:

Eigner U.1,Schmid A.1,Wild U.1,Bertsch D.1,Fahr A.-M.1

Affiliation:

1. Department of Microbiology, Laboratory Group Heidelberg, D-69126 Heidelberg, Germany

Abstract

ABSTRACT The VITEK 2 (bioMérieux, Marcy L′Ètoile, France) and the Phoenix systems (BD Diagnostic Systems, Sparks, Md.) are automated instruments for rapid organism identification and susceptibility testing. We evaluated the workflow, the time to result, and the performance of identification and susceptibility testing of both instruments. A total of 307 fresh clinical isolates were tested: 141 Enterobacteriaceae , 22 nonfermenters, 93 Staphylococcus spp., and 51 Enterococcus spp. Manipulation time was measured in batches, each with seven isolates, for a total of 39 batches. The mean (± standard deviation [SD]) manipulation time per batch was 20.9 ± 1.8 min for Phoenix and 10.6 ± 1.0 min for VITEK 2 ( P < 0.001). Mean (±SD) time to result for all bacterial groups was 727 ± 162 min for Phoenix and 506 ± 120 min for VITEK 2 ( P < 0.001). Concerning identification, Phoenix and VITEK 2 yielded the same results for nonfermenters (100%), staphylococci (97%), and enterococci (100%). For 140 Enterobacteriaceae strains evaluated, 135 (96%) were correctly identified by Phoenix and 137 (98%) by VITEK 2 ( P = 0.72). The overall category agreement for all isolates was 97.0% for both instruments. The minor error rate, major error rate, and very major error rate for all bacterial isolates tested were 3.0, 0.3, and 0.6 and 2.8, 0.2, and 1.7 for Phoenix and VITEK 2, respectively ( P values of 0.76, 0.75, and 0.09). The VITEK 2 system required less manual manipulation time and less time than the Phoenix system to yield results.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Reference17 articles.

1. Abele-Horn, M., S. Suerbaum, and M. Frosch. 2002. Evaluierung des VITEK 2 in der Routinediagnostik. Mikrobiologe12:203-215.

2. Clinical and Financial Benefits of Rapid Bacterial Identification and Antimicrobial Susceptibility Testing

3. Improved Antimicrobial Interventions Have Benefits

4. Center for Devices and Radiological Health 2000. Guidelines on review criteria for assessment of antimicrobial susceptibility devices. U.S. Department of Health and Human Services Food and Drug Administration Washington D.C.

5. Clinical impact of rapid in vitro susceptibility testing and bacterial identification

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3